Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Horney, Mark J ^a   Shirley, David W ^a   Kurtz, David T ^a   Rosenzweig, Steven A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Diabetes; Glomerulosclerosis; Hyperglycemia; Proliferation; Tyrosine phosphorylation

Indexed keywords

SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; DIABETES MELLITUS; GLOMERULOSCLEROSIS; INSULIN TREATMENT; LIGAND BINDING; MESANGIUM CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR BINDING; STATISTICAL ANALYSIS;

EID: 0031869646     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.6.f1045     Document Type: Article

References (53)

1. Ayo, S. H., R. A. Radnik, J. A. Garoni, W. F. Glass II, and J. I. Kreisberg. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am. J. Pathol. 136: 1339-1348, 1990.
2. Bach, L. A., and G. Jerums. Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 39: 557-562, 1990.
3. Bach, L. A., and M. M. Rechler. Insulin-like growth factors and diabetes. Diabetes Metab. Rev. 8: 221-257, 1992.
4. Border, W. A., S. Okuda, L. R. Languino, and E. Ruoslathi. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int. 37: 689-695, 1990.
5. Bradshaw, S. L., and V. K. Han. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin. Endocrinology 133: 1767-1777, 1993.
6. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B. R. Selzinger, and N. Kley. Induction of growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649, 1995.
7. Camacho-Hubner, C., D. R. Clemmons, and A. J. D'Ercole. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. Endocrinology 129: 1201-1206, 1991.
8. Cohen, P, D. M. Peehl, H. C. Graves, and R. G. Rosenfeld. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol. 142: 407-415, 1994.
9. Cohick, W. S., M. A. McGuire, D. R. Clemmons, and D. E. Bauman. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology 130: 1508-1514, 1992.
10. Cohick, W. S., A. Gockerman, and D. R. Clemmons. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. J. Cell. Physiol. 157: 52-60, 1993.
11. Coleman, M. E., and T. D. Etherton. Effects of exogenous porcine growth hormone on serum insulin-like growth factor-binding proteins in growing pigs. J. Endocrinol. 128: 175-180, 1991.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
13. Doi, T., L. J. Striker, C. C. Gibson, L. Y. C. Agodoa, R. L. Brinster, and G. E. Striker. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I: relationship between increased glomerular size and mesangial sclerosis. Am. J. Pathol. 137: 541-552, 1990.
14. Durham, S. K., B. L. Riggs, and C. A. Conover. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-β. J. Clin. Endocrinol. Metab. 79: 1752-1758, 1994.
15. Engerman, R., J. M. B. Bloodworth, Jr., and S. Nelson. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760-769, 1977.
16. 12 myoblasts. J. Endocrinol. 149: 417-429, 1996.
17. Feld, S. M., R. Hirschberg, A. Artishevsky, C. Nast, and S. G. Adler. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int. 48: 45-51, 1995.
18. Fervenza, F. C., T. Tsao, A. R. Hoffman, and R. Rabkin. Regional changes in the intrarenal insulin-like growth factor-I axis in diabetes. Kidney Int. 51: 811-818, 1997.
19. 281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J. Biol. Chem. 266: 19469-19474, 1991.
20. Flyvbjerg, A., J. Frystyk, O. Thorlacius-Ussing, and H. Orskov. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32: 261-265, 1989.
21. Gavin, J. R., K. G. M. M. Alberti, M. B. Davidson, R. A. DeFronzo, A. Drash, S. G. Gabbe, S. Genuth, M. I. Harris, R. Kahn, H. Keen, W. C. Knowler, H. Lebovitz, N. K. Maclaren, J. P. Palmer, P. Raskin, R. A. Rizza, and M. P. Stern. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197, 1997.
22. Gockerman, A., and D. R. Clemmons. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76: 514-521, 1995.
23. Hardouin, S., M. Gourmelen, P. Noguiez, D. Seurin, M. Roghani, Y. Le Bouc, G. Povoa, T. J. Merimee, P. Hossenlopp, and M. Binoux. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J. Clin. Endocrinol. Metab. 69: 1291-1301, 1989.
24. Hossenlopp, P., D. Seurin, B. Segovia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154: 138-143, 1986.
25. Huynh, H., X. Yang, and M. Pollack. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J. Biol. Chem. 271: 1016-1021, 1996.
26. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
27. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. Landau, D., E. Chin, C. Bondy, H. Domene, C. T. Roberts, Jr., H. Gronbaek, A. Flyvbjerg, and D. LeRoith. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136: 1835-1842, 1995.
29. Lee, S. M., and R. Bressler. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 30: 106-111, 1981.
30. Mauer, S. M., M. W. Steffes, E. N. Ellis, D. E. R. Sutherland, D. M. Brown, and F. C. Goetz. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155, 1984.
31. 2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry 35: 8769-8775, 1996.
32. Moran, A., D. M. Brown, Y. Kim, and D. J. Klein. Effects of IGF-I and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes 40: 1346-1354, 1991.
33. Oemar, B. S., H. G. Foellmer, L. Hodgdon-Anandaut, and S. A. Rosenzweig. Regulation of insulin-like growth factor I receptors in diabetic mesangial cells. J. Biol. Chem. 266: 2369-2373, 1991.
34. Oemar, B. S., N. M. Law, and S. A. Rosenzweig. Insulin-like growth factor-1 induces tyrosyl phosphorylation of nuclear proteins. J. Biol. Chem. 266: 24241-24244, 1991.
35. Park, J. H. Y., R. H. McCusker, J. A. Vanderhoof, H. Mohammadpour, R. F. Harty, and R. G. MacDonald. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology 131: 1359-1368, 1992.
36. Pricci, F., G. Pugliese, G. Romano, G. Romeo, N. Locuratolo, F. Pugliese, P. Mené, G. Galli, A. Casini, C. M. Rotella, and U. Di Mario. Insulin-like growth factors I and II stimulated extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor-β. Endocrinology 137: 879-885, 1996.
37. Pugliese, G., F. Pricci, N. Locuratolo, G. Romeo, G. Romano, S. Giannini, B. Cresci, G. Galli, C. M. Rotella, and U. Di Mario. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production. Diabetologia 39: 775-784, 1996.
38. Quinn, L. S., B. Steinmetz, A. Maas, L. Ong, and M. Kaleko. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J. Cell. Physiol. 159: 387-398, 1994.
39. Reichard, P., and U. Rosenqvist. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J. Intern. Med. 226: 81-87, 1989.
40. Rosenzweig, S. A., B. S. Oemar, N. M. Law, U. T. Shankavaram, and B. S. Miller. Insulin like growth factor 1 receptor signal transduction to the nucleus. Adv. Exp. Med. Biol. 343: 159-168, 1993.
41. Ross, M., G. L. Francis, L. Szabo, J. C. Wallace, and F. J. Ballard. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3)-IGF-I. Biochem. J. 258: 267-272, 1989.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989, pp 16.32-16.36.
43. Schreiber, B. D., M. L. Hughes, and G. C. Groggel. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components. Clin. Nephrol. 43: 368-374, 1995.
44. Seed, B., and J.-Y. Sheen. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67: 271-277 1988.
45. Serri, O., H. Beauregad, P. Brazeau, T. Abribat, J. Lambert, A. Harris, and L. Vachon. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 265: 888-892, 1991.
46. Sharma, K., and F. N. Ziyadeh. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995.
47. Skaar, T. C., and C. R. Baumrucker. Regulation of insulin-like growth factor binding protein secretion by a murine mammary epithelial cell line. Exp. Cell Res. 209: 183-188, 1993.
48. Steffes, M. W., R. Osterby, B. Chavers, and S. M. Mauer. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989.
49. Striker, G. E., E. P. Peten, M. A. Carome, C. M. Pesce, K. Schmidt, C.-W. Yang, S. J. Elliot, and L. J. Striker. The kidney disease of diabetes mellitus (KDDM): a cell and molecular biology approach. Diabetes Metab. Rev. 9: 37-56, 1993.
50. Tsukazaki, T., T. Usa, T. Matsumoto, H. Enomoto, A. Ohtsuru, H. Namba, K. Iwasaki, and S. Yamashita. Effect of transforming growth factor-β on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp. Cell Res. 215: 9-16, 1994.
51. United States Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1997, p. 29.
52. Werner, H., Z. Shen-Orr, B. Stannard, B. Burguera, C. T. Roberts, Jr., and D. LeRoith. Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney. Diabetes 39: 1490-1497, 1990.
53. Wolf, G., K. Sharma, Y. Chen, M. Ericksen, and F. N. Ziyadeh. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int. 42: 647-656, 1992.